Similarly, according to the literature, patients with Haemophilia A and inhibitors to FVIII who experience acute bleeding events during ITI and are managed with on-demand bypassing therapies will almost inevitably lead to the development and/or worsening of haemophilic arthropathy [11]. Here, F8 is linked to hemophilia A.